A Study of LY2510924 and Durvalumab in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Durvalumab
Related studies linked through entity extraction aliases.
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Durvalumab (MEDI4736) in Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2